Arete Wealth Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$970K Buy
14,810
+97
+0.7% +$6.56K 0.06% 247
2026
Q2
$942K Buy
+14,713
New +$967K 0.06% 231
2025
Q3
– Sell
-9,612
Closed -$712K – 489
2025
Q2
$712K Sell
9,612
-176
-2% -$12.3K 0.05% 318
2025
Q1
$790K Sell
9,788
-107
-1% -$9.2K 0.06% 284
2024
Q4
$774K Sell
9,895
-3
-0% -$255 0.06% 305
2024
Q3
$924K Sell
9,898
-605
-6% -$50.8K 0.08% 234
2024
Q2
$814K Buy
10,503
+40
+0.4% +$3.26K 0.07% 278
2024
Q1
$951K Sell
10,463
-86
-0.8% -$7.16K 0.09% 217
2023
Q4
$816K Buy
10,549
+40
+0.4% +$2.8K 0.06% 294
2023
Q3
$715K Buy
10,509
+2,677
+34% +$195K 0.12% 182
2023
Q2
$636K Buy
7,832
+3,598
+85% +$287K 0.06% 314
2023
Q1
$347K Buy
+4,234
New +$302K 0.03% 435

Other funds holding GEHC

Arete Wealth Advisors's GEHC Position: Q3 2026 in Review

Arete Wealth Advisors increased its GE HealthCare (GEHC) stake by 0.66% in Q3 2026, buying an estimated $6.56K and bringing the position to 14,810 shares worth $970K. The position accounts for 0.06% of the portfolio, ranked #247.

Arete Wealth Advisors first reported a position in GEHC in Q1 2023 and has held it in 12 quarters since. 752 funds tracked by Wall St. Rank hold GEHC as of Q3 2026.

  • Arete Wealth Advisors held 14,810 shares of GE HealthCare worth $970K as of Q3 2026.
  • Arete Wealth Advisors bought 97 GE HealthCare shares in Q3 2026, an estimated $6.56K.
  • GE HealthCare made up 0.06% of Arete Wealth Advisors's portfolio in Q3 2026, its #247 holding.
  • Arete Wealth Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 12 quarters since.
  • 752 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2026.

Based on Arete Wealth Advisors's 13F filing for Q3 2026, filed 9 Nov 2026.